GeneDx Holdings WGS
NASDAQ WGS
$101.10 -3.85 (-3.67%)
At close: Sep 18, 2026 · 4:00 PM EDT

GeneDx Holdings (WGS) Long-Term Deferred Tax (2020 - 2021)

GeneDx Holdings' (WGS) quarterly Long-Term Deferred Tax came in at $426000.0 in Q1 2021, up 954.46% quarter-over-quarter from $40400.0 in Q4 2020.

Analysis

GeneDx Holdings (WGS) Long-Term Deferred Tax (2020 - 2021) Analysis & Trends

GeneDx Holdings (WGS) has reported Long-Term Deferred Tax for 2 consecutive years, with $426000.0 the latest figure, recorded in Q1 2021.

  • On a quarterly basis, Long-Term Deferred Tax changed N/A year-over-year to $426000.0 in Q1 2021; TTM through Mar 2021 was $426000.0, a N/A change from a year earlier, with the FY2020 full-year figure at $40400.0, changed N/A from the prior year.
  • Long-Term Deferred Tax was $426000.0 for Q1 2021 at GeneDx Holdings, up from $40400.0 in the prior quarter.
  • Over five years, Long-Term Deferred Tax peaked at $426000.0 in Q1 2021 and troughed at $12000.0 in Q3 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Natera 53.05 Bn 51.95 Bn 486.15 Mn
2 Quest Diagnostics 27.19 Bn 26.87 Bn 1.03 Bn
3 Labcorp Holdings 25.93 Bn 25.81 Bn 1.11 Bn
4 Guardant Health 23.97 Bn 22.91 Bn 219.03 Mn
5 Tempus AI 13.64 Bn 12.82 Bn 274.25 Mn
6 Caris Life Sciences 8.47 Bn 7.68 Bn 182.38 Mn
7 Sotera Health 5.35 Bn 4.99 Bn 177.96 Mn
8 BillionToOne 4.96 Bn 4.41 Bn 77.11 Mn
9 Adaptive Biotechnologies 4.55 Bn 4.21 Bn 51.39 Mn
10 GeneDx Holdings 3.01 Bn 2.88 Bn 78.24 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 426,000.00
Dec 31, 2020 40,400.00
Sep 30, 2020 12,000.00